Can knowing you and your family may get Alzheimer’s ever be positive?
By Giulia Rhodes,
The Guardian
| 09. 21. 2015
Untitled Document
At the University of Washington’s School of Medicine there is a computer database that states with certainty – albeit heavily encrypted – whether or not Sophie Leggett will develop a form of genetically inherited early onset Alzheimer’s disease. But she has chosen not to find out what it says.
A blood test is available to adult children and siblings of those who develop Alzheimer’s at a young age and have a family history of the disease. It identifies whether they carry one of the three faulty genes known to cause familial early onset Alzheimer’s, presenilin 1 (the mutation affecting Leggett’s family), presenilin 2 and amyloid precursor protein. All result in the overproduction of amyloid, a protein that builds up into the plaques on the brain which are the hallmark of Alzheimer’s.
Now 39, Leggett saw her mother and aunt develop familial early onset Alzheimer’s in their early 40s – as had their father. All died in their 50s. There is a one-in-two chance that Leggett has inherited the gene mutation.
“I focus on the 50% chance that...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...